Inflammatory Genes in Epicardial Fat Contiguous With Coronary Atherosclerosis in the Metabolic Syndrome and Type 2 Diabetes: Changes associated with pioglitazone - Sacks, Harold S; Fain, John N; Cheema, Paramjeet; Bahouth, Suleiman W; Garrett, Edward; Wolf, Rodney Y; Wolford, David; Samaha, Joseph (Diabetes care, 2011)
Keywords: adipose tissue; antagonists; Atherosclerosis; Biological and medical sciences; coronary artery disease; Coronary Artery Disease - drug therapy; Coronary Artery Disease - genetics; Diabetes; Diabetes Mellitus, Type 2; Diabetes Mellitus, Type 2 - drug therapy; Diabetes Mellitus, Type 2 - genetics; Diabetes. Impaired glucose tolerance; Diagnosis; Drug therapy; Endocrine pancreas. Apud cells (diseases); Endocrinopathies; Etiopathogenesis. Screening. Investigations. Target tissue resistance; Gene expression; gene expression regulation; genes; genetics; Humans; Hypoglycemic Agents; Hypoglycemic Agents - therapeutic use; Insulin resistance; Interleukin 1 Receptor Antagonist Protein; Interleukin 1 Receptor Antagonist Protein - genetics; interleukin-10; Interleukin-10 - genetics; interleukin-1beta; Interleukin-1beta - genetics; Medical sciences; messenger RNA; Metabolic diseases; metabolic syndrome; Metabolic Syndrome - drug therapy; Metabolic Syndrome - genetics; metabolism; Miscellaneous; noninsulin-dependent diabetes mellitus; Original Research; Other metabolic disorders; patients; Pericardium; Pericardium - metabolism; Polymerase chain reaction; Public health. Hygiene; Public health. Hygiene-occupational medicine; Reverse Transcriptase Polymerase Chain Reaction; Risk factors; Statistical methods; Studies; surgery; therapeutic use; Thiazolidinediones; Thiazolidinediones - therapeutic use; Type 2 diabetes; United States; Endocrinopathy; Type 2 diabetes; Human; Agonist; Nutrition; Pioglitazone; Coronary artery; Epicardium; Cardiovascular disease; Metabolic diseases; Thiazolidinedione derivatives; Inflammation; Change; PPAR-γ receptor; Metabolic syndrome; Coronary heart disease; Vascular disease; Hypoglycemic agent; Association; Gene; Atherosclerosis; Fat; Genetics; Endocrinology